Potential Dupilumab‐Induced Unmasking of Specific Immunoglobulin Deficiency: A First‐of‐Its‐Kind Case
Roshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem · 2026
Read Potential Dupilumab‐Induced Unmasking of Specific Immunoglobulin Deficiency: A First‐of‐Its‐Kind Case by Roshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem (2026) in the Tower of Babel, a free online library of public-domain works preserved in clean, searchable text. No sign-up. The full text is served as a plain-text file at a predictable URL, where text is present: https://antarctic-labs.com/tower-of-babel/pmc-13197888.txt.
Description
Bista and co-authors report a case where a common allergy and asthma drug may have exposed a hidden immune defect, in a 2026 case report. The drug, dupilumab, blocks a signal that helps B cells mature and swap antibody types. A 45-year-old woman with severe asthma and sinus disease began the drug after standard therapy failed. A year later she developed a severe chest infection with MRSA bacteria and fluid around the lung.
A second such episode came two years later. Blood tests showed falling antibody levels and a weak response to a pneumonia vaccine, pointing to a specific antibody deficiency. The timing suggests the drug unmasked a defect that had stayed silent. The authors urge awareness of this first reported link.
Catalog record
| CREATOR | Roshani Bista, Debbie Aishwarya Sathya, Sushan Gupta, Danish Thameem |
|---|---|
| YEAR | 2026 |
| COLLECTION | PAPERS |
| FORMAT | TXT |
| FILE SIZE | 16 KB |
| VERSION | 1.0 |
| LICENSE | CC BY 4.0 |
| RIGHTS | CC BY |
| SOURCE | Europe PMC |